[33, 34, 35, 36] Mechanism: Typically pre-renal, occurring in the setting of volume depletion from GI losses (nausea, vomiting, diarrhea, reduced oral intake) More frequently seen at higher, obesity-level doses Although generally reno-protective long term, post-marketing data describe acute rises in creatinine following days to weeks of significant GI symptoms Risk factors: Underlying chronic kidney disease Concomitant use of ACE inhibitors, ARBs, diuretics, or SGLT2 inhibitors ED Management: IV fluids Hold GLP-1 and contributing medications Usually reversible with supportive care Future Directions GLP-1 receptor agonists are rapidly evolving beyond their original indications in diabetes and obesity
Love the little pep of energy it gives me for my workouts
Acute overdose is unlikely to cause serious harm rodent LD50 data suggest a wide safety margin but doubling dose wont double cognitive benefits due to receptor saturation
Lightweight watery texture absorbs quickly without sticky residue, suitable for daily anti-aging maintenance of all skin types
Cutaneous adverse drug reactions in hospitalised patients
The famous IV is a mixture of magnesium, calcium, B-Vitamins , B-complex and Vitamin C